GO:0070901 mitochondrial tRNA methylation: Mitochondrial Translation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070901 mitochondrial tRNA methylation is the posttranscriptional addition of methyl groups to specific residues in mitochondrial tRNA molecules, a process required for accurate and efficient mitochondrial translation.
• Loss of mitochondrial tRNA methylation, particularly at position 37 (m1G37) and position 58 (m1A58), causes mitochondrial translation defects, respiratory chain deficiency and metabolic stress.
• The enzymes TRMT5 (m1G37) and TRMT61B (m1A58) are the principal mitochondrial tRNA methyltransferases, and their activity is folate-dependent and sensitive to one-carbon metabolism.
• Dysregulated mitochondrial tRNA methylation is observed in Alzheimer's disease, progressive supranuclear palsy, cancer metastasis and drug-resistant leukemia, making it a disease-relevant pathway.
• Mitochondrial tRNA methylation can be studied with Ribo-seq, RNA-seq, mass spectrometry, bisulfite/NaBH4-based modification mapping and CRISPR knockout models.
• EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression and library screening services to dissect the causal role of mitochondrial tRNA methylation genes in disease models.
Description
Mitochondrial tRNA methylation (GO:0070901) is a conserved posttranscriptional RNA modification process in which methyl groups are covalently added to specific nucleotides of mitochondrial tRNA molecules. This modification is essential for the structural stability and decoding fidelity of mitochondrial tRNAs, which are encoded by the mitochondrial genome and are required for the synthesis of 13 oxidative phosphorylation (OXPHOS) subunits. Because mitochondrial translation is the sole source of these OXPHOS proteins, defects in tRNA methylation directly impair cellular respiration and energy metabolism. Researchers study GO:0070901 to understand how mitochondrial gene expression is regulated, how metabolic states such as folate availability influence translation, and how RNA modification enzymes contribute to human disease. The pathway has emerged as a therapeutic vulnerability in cancer and neurodegeneration, where altered mitochondrial tRNA methylation reshapes metabolic plasticity and cell survival.
mitochondrial tRNA methylation At A Glance
| GO ID | GO:0070901 |
|---|---|
| GO term | mitochondrial tRNA methylation |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Definition | The posttranscriptional addition of methyl groups to specific residues in a mitochondrial tRNA molecule. |
| Major function | Posttranscriptional methylation of mitochondrial tRNA that supports tRNA stability, decoding fidelity and mitochondrial translation. |
| Key enzymes | TRMT5 (m1G37) and TRMT61B (m1A58) are the principal mitochondrial tRNA methyltransferases. |
| Cofactor dependency | Folate-dependent one-carbon metabolism supplies methyl groups for mitochondrial tRNA methylation. |
| Disease relevance | Alzheimer's disease, progressive supranuclear palsy, cancer metastasis and drug-resistant leukemia. |
What Is GO:0070901?
GO:0070901 mitochondrial tRNA methylation is defined by QuickGO as the posttranscriptional addition of methyl groups to specific residues in a mitochondrial tRNA molecule. In practice, this means that after mitochondrial tRNAs are transcribed and processed, dedicated methyltransferase enzymes recognize particular nucleotides and transfer a methyl group from a donor such as S-adenosylmethionine onto the base or ribose, generating modified residues including 1-methylguanosine (m1G), 1-methyladenosine (m1A) and 2-methylguanosine (m2G). These modifications are deposited at defined positions within the tRNA cloverleaf structure and are required for proper tRNA folding, codon-anticodon pairing and interaction with the mitochondrial ribosome.
Why Is mitochondrial tRNA methylation Important in Cell Biology?
Mitochondrial tRNA methylation is important because it sits at the intersection of one-carbon metabolism, mitochondrial gene expression and cellular energy homeostasis. Without proper methylation, mitochondrial tRNAs are destabilized and mitochondrial translation is impaired, leading to reduced OXPHOS capacity and increased metabolic stress. This pathway is also dynamically regulated in disease: altered mitochondrial tRNA methylation has been reported in Alzheimer's disease and progressive supranuclear palsy, and it shapes metabolic plasticity during cancer metastasis and drug resistance in leukemia. Consequently, GO:0070901 is a high-value target for researchers studying mitochondrial disease, neurodegeneration and cancer metabolism.
• Required for efficient mitochondrial translation and OXPHOS complex assembly.
• Folate-dependent, linking diet and one-carbon metabolism to mitochondrial function.
• Loss of m1G37 or m1A58 causes mitochondrial translation defects and respiratory chain deficiency.
• Dysregulated in Alzheimer's disease and progressive supranuclear palsy.
• Supports metabolic plasticity in cancer metastasis.
• Represents a vulnerability in drug-resistant leukemia cells.
• Involved in paternal mitochondrial elimination in model organisms.
• Provides a mechanistic link between RNA modification and mitochondrial pathology.
• Can be targeted with CRISPR models to test causality in disease.
• Offers biomarkers and therapeutic entry points for mitochondrial disease.
What Happens During mitochondrial tRNA methylation?
Transcription and processing of mitochondrial tRNA
In simple terms: First, the mitochondrial genome makes tRNA molecules that must be trimmed and folded before they can work.
Mitochondrial tRNAs are transcribed from the mitochondrial genome and processed into mature molecules that fold into the canonical cloverleaf structure. These tRNAs are essential for translating the 13 mitochondrially encoded OXPHOS subunits, and their maturation is a prerequisite for the methylation steps that follow.
Recognition of target residues by mitochondrial tRNA methyltransferases
In simple terms: Special enzymes find specific spots on the tRNA and get ready to add a chemical tag.
Dedicated methyltransferases recognize defined positions within mitochondrial tRNA. TRMT5 catalyzes the formation of 1-methylguanosine at position 37 (m1G37), while TRMT61B catalyzes 1-methyladenosine at position 58 (m1A58). These enzymes discriminate their substrates through sequence and structural features of the tRNA, ensuring modification at the correct residue.
Methyl group transfer from S-adenosylmethionine
In simple terms: The enzyme takes a methyl group from a donor molecule and attaches it to the tRNA base.
The catalytic step transfers a methyl group from S-adenosylmethionine to the target nucleotide, generating modified bases such as m1G and m1A. This reaction is dependent on folate-mediated one-carbon metabolism, which supplies the methyl donor pool and links mitochondrial tRNA methylation to nutrient status.
Folding, stability and codon-anticodon pairing
In simple terms: The chemical tag helps the tRNA keep its shape and read the genetic code correctly.
Methylation at positions 37 and 58 stabilizes mitochondrial tRNA structure and supports accurate codon-anticodon interactions during translation. Loss of these modifications leads to tRNA destabilization, decoding errors and reduced mitochondrial protein synthesis.
Integration with mitochondrial translation and OXPHOS assembly
In simple terms: Properly modified tRNAs allow mitochondria to build the protein machines that make energy.
Methylated mitochondrial tRNAs are required for efficient translation of mitochondrially encoded OXPHOS subunits. When methylation is impaired, mitochondrial translation is reduced, OXPHOS complexes are destabilized and cellular energy production declines, contributing to mitochondrial pathology.
Key Genes Involved in GO:0070901 mitochondrial tRNA methylation
The following genes and proteins are central to mitochondrial tRNA methylation (GO:0070901) and its downstream effects on mitochondrial translation and disease.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRMT5 | Catalyzes m1G37 methylation of mitochondrial tRNA | Loss causes mitochondrial translation defects and respiratory chain deficiency |
| TRMT61B | Catalyzes m1A58 methylation of mitochondrial tRNA | Linked to metabolic plasticity and mitochondrial pathology |
| TRMT6 | Partner subunit of the TRMT6-TRMT61A complex for m1A methylation | Context for m1A tRNA modification studies |
| TRMT61A | Catalytic subunit for m1A methylation in tRNA | Dysregulated in Alzheimer's disease tRNA methylation |
| ALKBH1 | tRNA demethylase that removes m1A and influences mitochondrial tRNA methylation | Regulates paternal mitochondrial elimination and mitochondrial function |
| ALKBH3 | tRNA demethylase involved in m1A dynamics | Modulates tRNA methylation balance |
| MTHFD1L | Folate-dependent one-carbon metabolism enzyme | Supplies methyl groups for mitochondrial tRNA methylation |
| SHMT2 | Serine hydroxymethyltransferase in mitochondria | Supports one-carbon supply for tRNA methylation |
| MTR | Methionine synthase | Links folate cycle to methionine and SAM availability |
| MAT2A | Methionine adenosyltransferase | Generates S-adenosylmethionine for methylation reactions |
| NSUN2 | RNA m5C methyltransferase | Broader context of tRNA methylation crosstalk |
| FTSJ1 | 2'-O-methyltransferase | Related tRNA modification enzyme |
| METTL1 | m7G tRNA methyltransferase | Comparative tRNA modification studies |
| WDR4 | Partner of METTL1 | tRNA modification complex context |
| ELAC2 | Mitochondrial tRNA processing endonuclease | Upstream of tRNA methylation maturation |
| POLRMT | Mitochondrial RNA polymerase | Transcribes mitochondrial tRNA precursors |
| MTERF4 | Mitochondrial transcription termination factor | Regulates mitochondrial gene expression |
| LRPPRC | Mitochondrial mRNA stability factor | Coordinates mitochondrial gene expression with translation |
How Is mitochondrial tRNA methylation Regulated?
Mitochondrial tRNA methylation is regulated by the availability of methyl donors through folate-dependent one-carbon metabolism, which controls the supply of S-adenosylmethionine for TRMT5 and TRMT61B. In addition, demethylases such as ALKBH1 and ALKBH3 dynamically remove methyl groups, establishing a reversible modification balance that responds to cellular state. This balance is further influenced by metabolic cues and stress conditions that alter mitochondrial translation demand and one-carbon flux.
mitochondrial tRNA methylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRMT5 | Mitochondrial translation deficiency and respiratory chain defects | TRMT5 knockout cells with OXPHOS profiling |
| TRMT61B | Cancer metabolic plasticity and metastasis | TRMT61B knockout or overexpression in cancer cell lines |
| ALKBH1 | Paternal mitochondrial elimination and mitochondrial quality control | ALKBH1 knockout models with mitochondrial inheritance assays |
| TRMT61A | Alzheimer's disease tRNA methylation dysregulation | TRMT61A knockdown in neuronal models |
| MTHFD1L | Folate-dependent mitochondrial translation defects | MTHFD1L knockout cells with folate restriction |
Mitochondrial tRNA methylation in neurodegeneration
Dysregulated mitochondrial and cytosolic tRNA m1A methylation has been reported in Alzheimer's disease, and mitochondrial tRNA methylation changes are observed in Alzheimer's disease and progressive supranuclear palsy. These findings suggest that altered tRNA modification contributes to mitochondrial dysfunction in neurodegenerative disease.
Mitochondrial tRNA methylation in cancer metabolism and metastasis
Mitochondrial RNA modifications, including tRNA methylation, shape metabolic plasticity during metastasis, supporting the idea that cancer cells rewire mitochondrial translation to survive and spread. Disrupting tRNA modifications has also been proposed as a strategy to target mitochondrial vulnerabilities in drug-resistant leukemia cells.
Mitochondrial tRNA methylation and mitochondrial pathology
Posttranscriptional methylation of mitochondrial tRNA differentially contributes to mitochondrial pathology, with loss of specific modifications causing distinct translation and respiratory defects. These studies link GO:0070901 directly to mitochondrial disease mechanisms.
Mitochondrial tRNA methylation in mitochondrial inheritance
ALKB-1-dependent tRNA methylation is required for efficient paternal mitochondrial elimination, connecting tRNA methylation to mitochondrial inheritance and quality control.
From mitochondrial tRNA methylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TRMT5 cause mitochondrial translation defects? | TRMT5 knockout cell line |
| Does TRMT61B m1A58 methylation regulate metabolic plasticity? | TRMT61B knockout and overexpression cancer cells |
| Is a specific catalytic residue of TRMT5 required for m1G37? | Point-mutation knock-in of TRMT5 catalytic mutant |
| Can tagged TRMT61B reveal its mitochondrial localization and interactome? | Tagged knock-in of TRMT61B |
| Does ALKBH1 demethylase activity control paternal mitochondrial elimination? | ALKBH1 knockout and point-mutation models |
| Can mitochondrial tRNA methylation genes be screened for disease modifiers? | CRISPR library screening in disease-relevant cells |
How to Study the mitochondrial tRNA methylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy on mitochondrial transcripts | Quantify translation defects after TRMT5 or TRMT61B loss |
| RNA-seq | Mitochondrial tRNA expression and modification changes | Compare disease versus control samples |
| Mass spectrometry | Levels of modified nucleosides m1G and m1A | Measure methyltransferase activity |
| CRISPR knockout | Loss-of-function effects of methylation genes | Test causality in mitochondrial pathology |
| CRISPR library screening | Fitness and drug-resistance phenotypes | Identify mitochondrial vulnerabilities in leukemia |
| Metabolic flux analysis | One-carbon and folate pathway activity | Link nutrient status to tRNA methylation |
| Mitochondrial respiration assays | OXPHOS capacity and oxygen consumption | Assess functional consequences of methylation loss |
| Imaging of mitochondrial morphology | Mitochondrial network integrity | Evaluate mitochondrial stress phenotypes |
Ribo-seq and mitochondrial translation profiling
Ribo-seq measures ribosome occupancy on mitochondrial transcripts and can reveal translation defects caused by loss of tRNA methylation. This method is used to quantify how m1G37 or m1A58 loss affects mitochondrial protein synthesis.
RNA-seq and tRNA modification mapping
RNA-seq and specialized modification mapping approaches detect changes in mitochondrial tRNA expression and methylation status. These methods are applied to compare disease and control samples, such as Alzheimer's disease brain tissue.
Mass spectrometry of modified nucleosides
Mass spectrometry can directly quantify modified nucleosides such as m1G and m1A in mitochondrial tRNA preparations. This provides a biochemical readout of methyltransferase activity and substrate specificity.
CRISPR-based functional genomics
CRISPR knockout and library screening enable systematic testing of mitochondrial tRNA methylation genes for roles in translation, metabolism and drug resistance. These approaches connect GO:0070901 to causal disease mechanisms.
How CRISPR Can Be Used to Study GO:0070901 mitochondrial tRNA methylation
Knockout
CRISPR knockout of TRMT5, TRMT61B or ALKBH1 removes the enzyme and reveals the consequences of losing mitochondrial tRNA methylation on translation, respiration and disease phenotypes.
Point Mutation
Point-mutation knock-in of catalytic residues in TRMT5 or TRMT61B separates methylation activity from other functions and tests whether enzymatic activity is required for mitochondrial translation.
Knock-in
Tagged knock-in of mitochondrial tRNA methyltransferases enables localization, interaction and dynamic tracking studies in living cells.
Overexpression
Overexpression of TRMT61B or TRMT5 can test whether increased methylation enhances mitochondrial translation or metabolic plasticity in cancer and neuronal models.
How EDITGENE Supports mitochondrial tRNA methylation Research
Researchers studying mitochondrial tRNA methylation-related genes often need to determine whether a candidate gene is causally involved in mitochondrial translation, metabolic stress or disease progression. EDITGENE provides publication-ready CRISPR models and screening services to test these hypotheses rigorously.
Contact EDITGENE today to design your custom CRISPR model for mitochondrial tRNA methylation research.
Frequently Asked Questions About mitochondrial tRNA methylation
What is mitochondrial tRNA methylation?
Mitochondrial tRNA methylation (GO:0070901) is the posttranscriptional addition of methyl groups to specific residues in mitochondrial tRNA molecules, which supports tRNA stability and mitochondrial translation.
What genes are involved in mitochondrial tRNA methylation?
Key genes include TRMT5 for m1G37, TRMT61B for m1A58, and demethylases such as ALKBH1, along with folate pathway genes like MTHFD1L and SHMT2.
Why is mitochondrial tRNA methylation important for mitochondrial translation?
Methylation at positions 37 and 58 stabilizes mitochondrial tRNA structure and supports accurate codon-anticodon pairing, which is required for efficient translation of OXPHOS subunits.
Is mitochondrial tRNA methylation folate-dependent?
Yes, mitochondrial translation requires folate-dependent tRNA methylation, linking one-carbon metabolism to mitochondrial gene expression.
How is mitochondrial tRNA methylation altered in Alzheimer's disease?
Dysregulated mitochondrial and cytosolic tRNA m1A methylation has been reported in Alzheimer's disease, and mitochondrial tRNA methylation changes are observed in Alzheimer's disease and progressive supranuclear palsy.
Does mitochondrial tRNA methylation affect cancer metastasis?
Mitochondrial RNA modifications, including tRNA methylation, shape metabolic plasticity in metastasis, suggesting a role in cancer progression.
Can mitochondrial tRNA methylation be targeted in leukemia?
Disrupting tRNA modifications has been proposed to target mitochondrial vulnerabilities in drug-resistant leukemia cells.
What methods are used to study mitochondrial tRNA methylation?
Common methods include Ribo-seq, RNA-seq, mass spectrometry of modified nucleosides, and CRISPR knockout or screening approaches.
What happens when TRMT5 is lost?
Loss of TRMT5-mediated m1G37 methylation impairs mitochondrial translation and causes respiratory chain deficiency.
How can CRISPR help study mitochondrial tRNA methylation?
CRISPR knockout, point-mutation, knock-in and overexpression models allow researchers to test the causal role of methylation enzymes in mitochondrial function and disease.
Conclusion
GO:0070901 mitochondrial tRNA methylation is a core posttranscriptional process that sustains mitochondrial translation and cellular energy metabolism. Its dysregulation is linked to neurodegeneration, cancer metastasis and drug-resistant leukemia, making it a compelling area for mechanistic and therapeutic research. CRISPR-based models and functional genomics provide a direct route to test causality and identify new targets within this pathway.
References
- 1. Maharjan S et al.. 2024. Post-transcriptional methylation of mitochondrial-tRNA differentially contributes to mitochondrial pathology.. Nat Commun 15(1):9008 PMID: 39424798
- 2. Morscher RJ et al.. 2018. Mitochondrial translation requires folate-dependent tRNA methylation.. Nature 554(7690):128-132 PMID: 29364879
- 3. Silzer TK et al.. 2020. Mitochondrial tRNA methylation in Alzheimer's disease and progressive supranuclear palsy.. BMC Med Genomics 13(1):71 PMID: 32429992
- 4. Luo Z et al.. 2026. ALKB-1-dependent tRNA methylation is required for efficient paternal mitochondrial elimination.. Nat Commun 17(1) PMID: 41611679
- 5. Shafik AM et al.. 2022. Dysregulated mitochondrial and cytosolic tRNA m1A methylation in Alzheimer's disease.. Hum Mol Genet 31(10):1673-1680 PMID: 34897434
- 6. Maharjan S et al.. 2023. Post-Transcriptional Methylation of Mitochondrial-tRNA Differentially Contributes to Mitochondrial Pathology.. bioRxiv PMID: 38106193
- 7. Delaunay S et al.. 2022. Mitochondrial RNA modifications shape metabolic plasticity in metastasis.. Nature 607(7919):593-603 PMID: 35768510
- 8. Pauli C et al.. 2025. Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells.. Blood 146(20):2443-2456 PMID: 40749163
